Page 112 - 《中国药房》2024年2期
P. 112

infantile  diarrhea  with  Saccharomyces  boulardii[J].  Med   the treatment of children with dyspepsia diarrhea[J]. Chin
               Forum,2012,16(23):3017-3018.                        J Mod Drug Appl,2020,14(20):141-143.
          [ 5 ]  文静. 儿童腹泻:如何正确使用益生菌[J]. 家庭医药(快                [15]  肖智辉,李博. 布拉氏酵母菌联合双歧杆菌三联活菌胶
               乐养生),2022(6):54.                                    囊治疗儿童病毒性腹泻的疗效观察[J]. 中国全科医学,
               WEN J. Diarrhea in children:how to use probiotics cor‐  2013,16(32):3119-3120.
               rectly[J]. Home Med,2022(6):54.                     XIAO  Z  H,LI  B.  Saccharomyces  boulardii  combined
          [ 6 ]  张玮娜,李梦甜. 布拉氏酵母菌与双歧杆菌三联活菌治                         with bifid-triple viable capsules in children with viral
               疗儿童腹泻伴发热的疗效观察[J]. 中国妇幼保健,2023,                      diarrhea[J]. Chin Gen Pract,2013,16(32):3119-3120.
               38(5):843-846.                                 [16]  胡艳霞. 布拉酵母菌散与双歧杆菌三联活菌胶囊佐治小
               ZHANG W N,LI M T. Clinical observation on the treat‐  儿抗生素相关性腹泻疗效比较[J]. 儿科药学杂志,2014,
               ment of diarrhea with fever in children with triple viable   20(4):22-24.
               bacteria of Saccharomyces boulardii and bifidobacterium  HU  Y  X.  Efficacy  comparison  between  Saccharomyces
               [J]. Matern Child Health Care China,2023,38(5):843-846.  boulardii sachets and triple viable bifidobacterium capsule
          [ 7 ]  李晓义,张晓华,张志华,等. 应用布拉酵母菌与双歧杆                        in  the  treatment  of  respiratory  tract  infection  with
               菌三联活菌治疗儿童轮状病毒性腹泻的疗效对比[J]. 吉                         antibiotic-associated diarrhea[J]. J Pediatr Pharm,2014,20
               林医学,2018,39(2):279-281.                            (4):22-24.
               LI X Y,ZHANG X H,ZHANG Z H,et al. The clinical   [17]  廖宏,禹教化,段胜稳. 微生态制剂治疗儿童腹泻的疗效
               outcome of Saccharomyces boulardii and triple viable bifi‐  及安全性分析[J]. 中国城乡企业卫生,2017,32(6):101-102.
               dobacterium  in  the  treatment  of  rotaviral  gastroenteritis   LIAO H,YU J H,DUAN S W. Efficacy and safety analysis
               for children[J]. Jilin Med J,2018,39(2):279-281.    of  microecological  agents  in  the  treatment  of  children’s
          [ 8 ]  胡会,张婷. 儿童腹泻病的诊治策略[J]. 上海医药,2022,                  diarrhea[J]. Chin J Urban Rural Enterp Hyg,2017,32(6):
               43(16):3-6,34.                                      101-102.
               HU H,ZHANG T. Diagnosis and treatment strategies of   [18]  崔玲. 微生态制剂对腹泻患儿临床症状改善及肠道菌群
               diarrhoea in children[J]. Shanghai Med Pharm J,2022,43  变化的影响[J]. 西藏医药,2017,38(3):7-10.
              (16):3-6,34.                                         CUI  L.  Efficacy  of  microecological  preparation  on  the
          [ 9 ]  ZENG X T,ZHANG Y G,KWONG J S,et al. The metho-    changes of intestinal flora and clinical symptoms for chil‐
               dological  quality  assessment  tools  for  preclinical  and    dren with diarrhea[J]. Tibet Med,2017,38(3):7-10.
               clinical studies,systematic review and meta-analysis,and   [19]  左林军. 急性腹泻的常见原因[J]. 家庭生活指南,2023,
               clinical practice guideline:a systematic review[J]. J Evid   39(8):193-194.
               Based Med,2015,8(1):2-10.                           ZUO L J. Common causes of acute diarrhea[J]. Fam Life
          [10]  ZHANG J W,WAN S,GUI Q Q. Comparison of safety,     Guide,2023,39(8):193-194.
               effectiveness  and  serum  inflammatory  factor  indexes  of   [20]  回晶,白琦琦,杨莹,等. 布拉氏酵母菌益生性和功能性
               Saccharomyces  boulardii  versus  Bifidobacterium  triple    的体外评价[J]. 辽宁大学学报(自然科学版),2022,49
               viable in treating children with chronic diarrhea:a rando-  (4):370-376.
               mized trial[J]. Transl Pediatr,2021,10(6):1677-1685.  HUI J,BAI Q Q,YANG Y,et al. In vitro evaluation of the
          [11]  刘铁英. 布拉氏酵母菌治疗婴幼儿肺炎继发腹泻的临床                          probiotic  characteristics  and  function  of  Saccharomyces
               研究[J]. 中国保健营养(上旬刊),2014,24(7):3736.                 cerevisiae boulardii[J]. J Liaoning Univ Nat Sci Ed,2022,
               LIU T Y. Brady’s yeast clinical research for the treatment   49(4):370-376
               of  infantile  pneumonia  secondary  diarrhea[J].  China   [21]  王忠敏,汤卫红,王惠庭,等. 布拉氏酵母菌散剂治疗抗
               Health Care Nutr,2014,24(7):3736.                   生素相关性腹泻疗效及对血TNF-α和IL-6水平影响[J].
          [12]  周琴芳. 不同方法治疗支气管肺炎儿童抗生素相关性腹                          浙江中西医结合杂志,2019,29(8):644-646.
               泻的临床分析[J]. 医药前沿,2017,7(12):44-45.                   WANG Z M,TANG W H,WANG H T,et al. Therapeutic
               ZHOU Q F. Clinical analysis of different methods in the   effect  of  Saccharomyces  boulardii  powder  on  antibiotic-
               treatment of antibiotic-associated diarrhea in children with   associated diarrhea and its influence on serum TNF-α and
               bronchopneumonia[J]. J Front Med,2017,7(12):44-45.  IL-6  levels[J].  Zhejiang  J  Integr Tradit  Chin West  Med,
          [13]  张亚红. 微生态制剂治疗小儿抗生素相关性腹泻的临床                          2019,29(8):644-646.
               观察[J]. 临床医学研究与实践,2017,2(6):116-117.            [22]  郑月连. 布拉酵母菌辅助治疗小儿轮状病毒性肠炎的疗
               ZHANG  Y  H.  Clinical  observation  on  the  treatment  of   效观察[J]. 基层医学论坛,2022,26(34):38-40,43.
               antibiotic-associated  diarrhea  in  children  with  microeco‐  ZHENG Y L. Clinical observation on the adjuvant treat‐
               logical preparations[J]. Clin Res Pract,2017,2(6):116-117.  ment of rotavirus enteritis in children with Saccharomyces
          [14]  李黎. 小儿消化不良性腹泻采取布拉氏酵母菌散治疗的                          boulardii[J]. Med Forum,2022,26(34):38-40,43.
               意义分析[J]. 中国现代药物应用,2020,14(20):141-143.                       (收稿日期:2023-08-10  修回日期:2023-11-29)
               LI L. Significance of Saccharomyces boulardii sachets in                           (编辑:陈 宏)



          · 230 ·    China Pharmacy  2024 Vol. 35  No. 2                               中国药房  2024年第35卷第2期
   107   108   109   110   111   112   113   114   115   116   117